Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating...
A recent study investigated whether an increase in access to PrEP would increase the likelihood of adherence to the medication. Do you think this would work in your practice?
Antibiotic resistance is one of the largest public health challenges in the United States and is a global health threat. What treatment options do we need in order to combat this public health challenge? ...
Herbal supplements have been used as alternative therapies for numerous medical conditions over the years. Would you ever consider using herbal supplements for treating uterine fibroids?
A recent study highlighted the barriers to therapy for patients with HIV/HCV coinfection. Have you experienced barriers to your patients receiving HCV therapy? Voice your opinion via our latest poll!
Over the past 20 years, there have been major advances in our understanding of pulmonary arterial hypertension, though many knowledge gaps still exist. Do you think gene discovery is a way forward?
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
EULAR updated its recommendations for treating rheumatoid arthritis with different therapeutic agents. Do you agree with its recommendation about initiating therapy for patients with RA?
